We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

27 hedge funds and large institutions have $12.9M invested in Cumberland Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

0.58% less ownership

Funds ownership: 27.2% → 26.62% (-0.58%)

6% less capital invested

Capital invested by funds: $13.8M → $12.9M (-$858K)

10% less funds holding

Funds holding: 30 → 27 (-3)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
27
Holders Change
-3
Holders Change %
-10%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
7
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PPA
Parametric Portfolio Associates
Washington
+$49.3K
2
BlackRock
BlackRock
New York
+$24.8K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$7.89K
4
TRCT
Tower Research Capital (TRC)
New York
+$5.19K
5
Osaic Holdings
Osaic Holdings
Arizona
+$740

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$286K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$104K
3
WS
Wedbush Securities
California
-$43K
4
Morgan Stanley
Morgan Stanley
New York
-$7.96K
5
UBS Group
UBS Group
Switzerland
-$6.35K
Name Holding Trade Value Shares
Change 		Change in
Stake
Dimensional Fund Advisors
1
Dimensional Fund Advisors
Texas
$2.56M -$104K -31,733 -4%
AI
2
Ariel Investments
Illinois
$2.51M – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$1.93M +$657 +200 +0%
SCM
4
Stonepine Capital Management
Oregon
$1.89M -$286K -87,095 -13%
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.26M – – –
BlackRock
6
BlackRock
New York
$1.17M +$24.8K +7,554 +2%
BCM
7
Bridgeway Capital Management
Texas
$587K – – –
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
$339K +$7.89K +2,400 +2%
California Public Employees Retirement System
9
California Public Employees Retirement System
California
$172K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$165K -$2.05K -624 -1%
Northern Trust
11
Northern Trust
Illinois
$74K -$145 -44 -0.2%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$65K – – –
UCFA
13
United Capital Financial Advisors
Texas
$52K – – –
PPA
14
Parametric Portfolio Associates
Washington
$48K +$49.3K +14,994 New
Cambridge Investment Research Advisors
15
Cambridge Investment Research Advisors
Iowa
$32K – – –
Morgan Stanley
16
Morgan Stanley
New York
$27K -$7.96K -2,420 -22%
Russell Investments Group
17
Russell Investments Group
United Kingdom
$16K – – –
OC
18
Oakworth Capital
Alabama
$10K – – –
TRCT
19
Tower Research Capital (TRC)
New York
$10K +$5.19K +1,578 +94%
UBS Group
20
UBS Group
Switzerland
$7K -$6.35K -1,932 -47%
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$6K +$30 +9 +0.4%
PAM
22
Panagora Asset Management
Massachusetts
$2K – – –
Fidelity Investments
23
Fidelity Investments
Massachusetts
$1K – – –
Osaic Holdings
24
Osaic Holdings
Arizona
$1K +$740 +225 +96%
WS
25
Wedbush Securities
California
– -$43K -13,041 Closed
1
2

CPIX Hedge Fund Activity: Q3 2020 in Review

27 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q3 2020, worth a combined $12.9M — down 6.2% from $13.8M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of CPIX and 1 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 7 added.

The largest buyer was Parametric Portfolio Associates, opening a new position worth an estimated $49.3K. The largest seller was Stonepine Capital Management, cutting an estimated $286K.

  • 27 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q3 2020, down from 30 in Q2 2020.
  • Funds reported $12.9M of Cumberland Pharmaceuticals stock for Q3 2020, down 6.2% quarter-over-quarter.
  • 1 fund opened new Cumberland Pharmaceuticals positions in Q3 2020 and 4 closed out, a net change of -3 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q3 2020 was Parametric Portfolio Associates, an estimated $49.3K added.
  • The largest Cumberland Pharmaceuticals seller in Q3 2020 was Stonepine Capital Management, an estimated $286K sold.

Based on aggregated 13F filings for Q3 2020.